Need immediate assistance? Call 1-518-730-0559 (Us-Canada Toll Free) or Contact Us

 

Pharmaceutical

Pharmaceutical Market Reports

  • Report Name
  • Published
  • Price
  • Sterile Injectable Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

    This report on sterile injectable drugs market studies the current as well as future prospects of the market globally. The stakeholders of this report include companies and intermediaries engaged in the manufacture, commercialization, providing sterile injectable drugs products as well as new entrants planning to enter this market. This report comprises an elaborate executive summary along with a market snapshot providing overall information of various segments and sub-segments considered in the scope of the study.

  • 2018-01-16
  • USD 5795
  • Women’s Health Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

    This report on the women’s health market analyzes the current and future scenario of the global market. Rise in number of women facing menopausal condition, rising incidence of women’s diseases, growing awareness among people about the availability of treatment for women’s health related diseases, technological advancements and high R&D investments are major factors driving market growth.

  • 2018-01-09
  • USD 5795
  • Pneumococcal Vaccines Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2026

    The prevention of disease through vaccination is one of the most cost-effective and safe ways. Pneumococcus is one of the leading causes of blood infection, pneumonia, sinusitis, meningitis, and otitis media. It is also one of the leading infectious diseases. However, it can be prevented with the help of vaccination. With an increase in pneumococcal disease due to causative serotype, the need for vaccines with broader coverage has increased. Hence, the demand for new pneumococcal vaccines with broader serotype coverage is increasing.

    Despite the availability of antibiotic therapy against pneumococcal disease, it remains a significant cause of death among people with increased susceptibility, such as older adults and also the people suffering from immunosuppressive conditions or chronic illness. However, reduction in the pneumococcal disease has been witnessed in the countries that introduced pneumococcal conjugate vaccines (PCV).

  • 2017-12-18
  • USD 5795